tiprankstipranks
Trending News
More News >
MedWellAI (MWAI)
OTHER OTC:MWAI
US Market

MedWellAI (MWAI) Price & Analysis

Compare
66 Followers

MWAI Stock Chart & Stats

$0.72
--
Market closed
$0.72
--

Bulls Say, Bears Say

Bulls Say
Revenue GrowthSustained TTM revenue growth of ~16% indicates product/market traction and demand stability. Over a multi-month horizon, revenue momentum supports scaling potential and provides a foundation for operating leverage if management can control costs and convert top-line gains into margin improvements.
Moderate Absolute DebtRelatively small absolute debt reduces near-term solvency pressure versus peers with heavy leverage. With limited debt service requirements, the firm has more flexibility to prioritize investment or restructuring, assuming it secures working capital despite other balance sheet strains.
Improving Free Cash Flow TrendAn improvement in free cash flow from previous multi-year burn signals that operations are moving toward cash stabilization. If this trend persists, it lowers ongoing funding needs and supports the firm's ability to fund core activities internally or reduce reliance on dilutive external financing.
Bears Say
Negative Shareholder EquityDeeply negative equity is a structural solvency concern that complicates financing and limits strategic options. It increases creditor reliance, can impair access to capital markets, and makes leverage metrics meaningless, raising medium-term default or restructuring risk without recapitalization.
Ongoing Net LossesSubstantial and persistent net losses with extremely negative margins indicate the core business is not yet profitable. Over several months this undermines reinvestment capacity, prolongs funding dependence, and challenges the firm's ability to generate sustainable returns absent a durable shift in unit economics or cost structure.
Negative Operating & Free Cash FlowOngoing negative operating and free cash flow forces reliance on external financing to run the business. Persistent cash burn constrains capital allocation, increases dilution or debt risk, and is a durable vulnerability until organic cash generation turns positive or capital structure is meaningfully strengthened.

MWAI FAQ

What was MedWellAI’s price range in the past 12 months?
MedWellAI lowest stock price was $0.20 and its highest was $0.80 in the past 12 months.
    What is MedWellAI’s market cap?
    MedWellAI’s market cap is $2.81M.
      When is MedWellAI’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were MedWellAI’s earnings last quarter?
      MedWellAI released its earnings results on Feb 18, 2025. The company reported -$0.127 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.127.
        Is MedWellAI overvalued?
        According to Wall Street analysts MedWellAI’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does MedWellAI pay dividends?
          MedWellAI does not currently pay dividends.
          What is MedWellAI’s EPS estimate?
          MedWellAI’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does MedWellAI have?
          MedWellAI has 6,236,580 shares outstanding.
            What happened to MedWellAI’s price movement after its last earnings report?
            MedWellAI reported an EPS of -$0.127 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of MedWellAI?
              Currently, no hedge funds are holding shares in MWAI
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                MedWellAI

                MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses. It provides AI-driven healthcare and wellness solutions. The company also offers a B2B e-commerce platform for distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management. In addition, it provides an AI-powered ordering system with inventory tracking, smart suggestions, and support for healthcare providers such as wellness clinics, med spas, and corporate wellness facilities. The company was formerly known as Integrated Ventures, Inc. and changed its name to MedWellAI Inc. in June 2025. The company is based in Clearwater, Florida.

                MedWellAI (MWAI) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Nvni Group
                Xiao-I Corp. ADR
                Simpple Ltd.
                Health In Tech, Inc. Class A
                Cloudastructure, Inc. Class A
                Popular Stocks